Mitochondrial Delivery of Therapeutic Agents by Amphiphilic DNA Nanocarriers.
Small
; 12(6): 770-81, 2016 Feb 10.
Article
em En
| MEDLINE
| ID: mdl-26690974
ABSTRACT
The first example of mitochondrial delivery of the anticancer drug doxorubicin (Dox) is presented by lipid-functionalized DNA nanocages (LNCs). Dox localized in mitochondria induces significant cytotoxicity and cellular apoptosis in MCF-7 compared with Dox localized in lysosomes. These results suggest that LNC has the potential to be an outstanding tool in the treatment of specific organelle-related diseases such as cancers.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Tensoativos
/
Portadores de Fármacos
/
Doxorrubicina
/
Nanopartículas
/
Mitocôndrias
Limite:
Humans
Idioma:
En
Revista:
Small
Assunto da revista:
ENGENHARIA BIOMEDICA
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
China